Improving NMR technology for studying biomolecules
Acquisition of 600 MHz NMR QCI-P CryoProbe and CryoPlatform
This study is all about using new technology to help scientists at Columbia University learn more about important molecules in our bodies, like fats and proteins, which can help us understand health and diseases better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10632601 on NIH RePORTER |
What this research studies
This research aims to acquire advanced NMR technology to enhance the study of biomolecules such as lipids, phosphoproteins, and nucleic acids. By installing a Bruker Biospin QCI-P CryoProbe and CryoPlatform on an existing NMR system, scientists will be able to conduct more sensitive and detailed experiments. This technology will facilitate research into the structure and dynamics of biomolecules, which is crucial for understanding health and disease mechanisms. The research will be conducted by a team of experts at Columbia University and affiliated research centers.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions related to lipid metabolism, phosphoprotein dysfunction, or nucleic acid abnormalities.
Not a fit: Patients with conditions unrelated to biomolecular structure or function may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in our understanding of biomolecular structures and their roles in health and disease.
How similar studies have performed: Previous research utilizing advanced NMR technology has shown promising results in understanding biomolecular interactions and dynamics.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Al-Hashimi, Hashim M — Columbia University Health Sciences
- Study coordinator: Al-Hashimi, Hashim M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.